Starpharma Holdings Ltd

  • IPO date:
  • Sector: Healthcare
  • GIC Group: Pharmaceuticals, Biotechnology & Life Sciences
  • Industry: Biotechnology
  • Company website

Company description

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom. It is also involved in the development of DEP cabazitaxel that is in Phase 2 clinical trial for the treatment of prostate and other cancers, DEP docetaxel that is in Phase 2 clinical trials for the treatment of colorectal and other cancers, DEP irinotecan that is in Phase 2 clinical trials f for the treatment of pancreatic and other cancers; and EP gemcitabine, DEP HER-2 ADC, and DEP HER-2 radiotherapy completed preclinical trials for the treatment of solid cancers. In addition, the company's DEP radiotheranostics development pipeline includes DEP HER2-zirconium, a HER2-targeted radio diagnostic for HER2-positive cancers, such as breast and gastric cancer; and HER2-targeted DEP SN38 ADC, a targeted ADC therapeutic for the treatment of human ovarian cancer. Starpharma Holdings Limited was incorporated in 1997 and is headquartered in Abbotsford, Australia.

Financial highlights

Market Capitalization$69.7838 million
P/E Ratio0
P/E Growth Ratio0
Book Value0.085
Dividend Per Share0
Earnings Per Share-0.04
EBITDA-15,381
Profit Margin0
Operating Margin TTM-3.7483
Return on Assets TTM-0.1667
Return on Equity TTM-0.3759
Revenue TTM4,208

Income statement highlights

All numbers are in thousands

Date Total Revenue Cost of Revenue Gross Profit Total Operating Expenses
1998-06-30
1999-06-30
2000-06-30 1,610 3,366
2001-06-30 1,964 18 5,583.879
2002-06-30 384.703 15 384.703 9,253.069
2003-06-30 911.335 439 911.335 8,783.569
2004-06-30 15.73 325 15.73 7,258.616
2005-06-30 13.922 372 13.922 10,387.708
2006-06-30 0.5 0.5 13,851.582
2007-06-30 863.854 863.854 19,328.43
2008-06-30 1,412 1,412 20,139
2009-06-30 2,019 2,019 16,143
2010-06-30 1,404 1,404 13,968
2011-06-30 1,144 1,144 13,749
2012-06-30 44 44 17,696
2013-06-30 20 20 8,704
2014-06-30 273 0 273 16,977
2015-06-30 804 0 804 21,863
2016-06-30 3,825 0 3,825 28,237
2017-06-30 2,992 0 2,992 19,751
2018-06-30 3,812 0 3,812 15,553
2019-06-30 1,651 251 1,400 17,021
2020-06-30 6,033 890 5,143 21,814
2021-06-30 1,798 791 1,007 23,362
2022-06-30 4,682 2,776 1,906 19,618
2023-06-30 2,939 1,120 1,819 20,055

Balance sheet highlights

All numbers are in thousands

Date Cash Total Assets Total Liabilities Short Term Debt Long Term Debt Common Stock
1998-06-30
1999-06-30
2000-06-30 28,079.314 29,052.555 199.281 33,065.252
2001-06-30 25,412.466 26,025.455 1,109.802 33,034.058
2002-06-30 17,434.235 18,859.433 1,593.106 33,034.058
2003-06-30 7,891.543 10,715.44 1,472.31 60.007 204 33,034.058
2004-06-30 15,658.3 18,490.942 898.446 60.007 144 46,821.956
2005-06-30 8,166.259 12,499.74 2,533.775 60.007 80 46,821.956
2006-06-30 14,283.824 25,013.065 3,697.079 142.092 315 65,375.467
2007-06-30 10,072.893 30,423.479 4,699.449 68.587 260 76,226.627
2008-06-30 7,482 24,653 4,270 124 293 78,667
2009-06-30 11,595 28,847 3,348 133 160 85,640
2010-06-30 22,851 37,567 2,723 160 101,766
2011-06-30 18,918 29,807 2,114 49 17 105,399
2012-06-30 42,812 54,268 5,617 40 100 139,171
2013-06-30 33,840 48,550 2,582 25 75 140,081
2014-06-30 24,028 36,862 3,911 27 48 140,349
2015-06-30 30,848 44,383 6,825 30 18 160,884
2016-06-30 45,972 59,039 9,615 18 193,512
2017-06-30 61,188 66,591 5,607 23 47 193,549
2018-06-30 51,319 58,511 5,234 26 23 193,583
2019-06-30 41,251 48,859 6,464 26 193,621
2020-06-30 30,054 39,078 7,752 604 193,661
2021-06-30 60,500 73,238 10,938 692 240,630
2022-06-30 49,918 66,175 17,782 695 4,000 240,669
2023-06-30 35,180 52,086 17,271 5,522 0 240,715

Cash flow highlights

All numbers are in thousands

Date Net Income Total Cash Change in Cash Begin period cash End period cash Dividends
2000-06-30 7,225.73
2001-06-30 -3,906.427 -2,453.735 18,186.736 7,225.73 25,412.466
2002-06-30 53.158 -7,310.669 -7,978.231 25,412.466 17,434.235
2003-06-30 -175.062 -9,542.692 17,434.235 7,891.543
2004-06-30 -5,807.179 7,766.757 7,891.543 15,658.3
2005-06-30 -7,585.992 -5,808.589 -7,492.041 15,658.3 8,166.259
2006-06-30 -7,522.789 -7,489.948 6,117.565 8,166.259 14,283.824
2007-06-30 -7,244.996 -3,380.194 -4,210.931 14,283.824 10,072.893
2008-06-30 -7,491 -5,352 -2,591 10,073 7,482
2009-06-30 -4,127 -4,029 4,113 7,482 11,595
2010-06-30 -6,378 -3,630 11,256 11,595 22,851
2011-06-30 -8,930 -6,476 -3,933 22,851 18,918
2012-06-30 -13,658 -9,770 23,894 18,918 42,812
2013-06-30 -5,229 -9,795 -8,972 42,812 33,840
2014-06-30 -14,635 -9,813 -9,812 33,840 24,028
2015-06-30 -18,950 -13,615 6,820 24,028 30,848
2016-06-30 -22,675 -17,811 15,124 30,848 45,972 0
2017-06-30 8,200 -16,955 15,216 45,972 61,188 0
2018-06-30 -10,285 -10,201 -9,869 61,188 51,319
2019-06-30 -14,254 -10,344 -10,068 51,319 41,251
2020-06-30 -14,678 -10,776 -11,197 41,251 30,054
2021-06-30 -19,732 -14,808 30,446 30,054 60,500
2022-06-30 -16,371 -15,293 -10,582 60,500 49,918
2023-06-30 -15,638 -13,533 -14,738 49,918 35,180